Biohit Oyj - ESG Rating & Company Profile powered by AI
The ESG score covers seventeen United Nations SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Life on Land'. Jump to the bottom of this page for potential risks for Biohit Oyj based on sector, location and marketcap. Other corporations in the scoring industry group for Biohit Oyj are displayed below.
Biohit Oyj in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Biohit Oyj | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biohit Oyj have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biohit Oyj disclose current and historical energy intensity?
Sign up for free to unlockDoes Biohit Oyj report the average age of the workforce?
Sign up for free to unlockDoes Biohit Oyj reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biohit Oyj disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biohit Oyj disclose cybersecurity risks?
Sign up for free to unlockDoes Biohit Oyj offer flexible work?
Sign up for free to unlockDoes Biohit Oyj have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biohit Oyj disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biohit Oyj conduct supply chain audits?
Sign up for free to unlockDoes Biohit Oyj disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biohit Oyj conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biohit Oyj disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biohit Oyj disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biohit Oyj disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biohit Oyj disclose water use targets?
Sign up for free to unlockDoes Biohit Oyj have careers partnerships with academic institutions?
Sign up for free to unlockDid Biohit Oyj have a product recall in the last two years?
Sign up for free to unlockDoes Biohit Oyj disclose incidents of discrimination?
Sign up for free to unlockDoes Biohit Oyj allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biohit Oyj issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biohit Oyj disclose parental leave metrics?
Sign up for free to unlockDoes Biohit Oyj disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biohit Oyj disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biohit Oyj disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biohit Oyj support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biohit Oyj disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biohit Oyj reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biohit Oyj involved in embryonic stem cell research?
Sign up for free to unlockDoes Biohit Oyj disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biohit Oyj disclose its waste policy?
Sign up for free to unlockDoes Biohit Oyj report according to TCFD requirements?
Sign up for free to unlockDoes Biohit Oyj disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biohit Oyj disclose energy use targets?
Sign up for free to unlockDoes Biohit Oyj disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biohit Oyj have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biohit Oyj
These potential risks are based on the size, segment and geographies of the company.
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company's diagnostic tests product range includes the GastroPanel test for diagnosing diseases of the stomach and associated risks; Biohit Active B12, a test for measuring the levels of active vitamin B12; Biohit Total, an indicator of vitamin D status; Biohit Calprotectin, a test for measuring human calprotectin; Helicobacter Pylori Quick Test and Helicobacter Pylori UFT300 Quick Test, a test methods to detect H. pylori infection from a biopsy sample during gastroscopy; ColonView Quick Test, a test for detection of fecal occult blood; Lactose Intolerance Quick Test; Celiac Disease Quick Test; and The GA-map Dysbiosis test, a gut microbiota DNA analysis tool. It also provides monoclonal antibodies for use in cellular pathology, neurobiology, oncology, and human gastric biomarkers research. In addition, the company offers acetaldehyde binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenges, which removes acetaldehyde in smoker's saliva. Further, it provides microplate readers and strip washers, quick test readers, and ThunderBolt, an automated immunoassay analyzer; and products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies, and service laboratory services. The company was founded in 1988 and is headquartered in Helsinki, Finland.